Literature DB >> 11179482

Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR.

A Miyamoto1, H Nagano, M Sakon, Y Fujiwara, Y Sugita, H Eguchi, M Kondo, I Arai, O Morimoto, K Dono, K Umeshita, S Nakamori, M Monden.   

Abstract

In order to detect a hematogenous spread of tumor cells in patients with hepatocellular carcinoma, reverse transcription-polymerase chain reaction assay has been used. In this study, we quantified alpha-fetoprotein (AFP) messenger RNA by real-time PCR approach using LightCyclertrade mark technique. AFP messenger RNA in the blood from 23 hepatocellular carcinoma patients undergoing hepatic resection, 31 healthy volunteers, 10 patients with liver cirrhosis and 5 patients underwent hepatectomy except for hepatocellular carcinoma was quantitated. In the real-time PCR, fluorescence was undetectable in any of the controls. On the contrary, fluorescent signals were detected in 10 out of 39 blood specimens collected from 23 HCC patients. AFP-positive status was significantly associated with the existence of multiple intrahepatic nodules. Out of 8 cases with AFP-positive status, intra- and/or extra-hepatic recurrence has been observed in 3 cases. The quantities of AFP messenger RNA in these 3 cases were relatively high among 8 cases with AFP-positive status. AFP messenger RNA was detectable by newly developed real-time PCR approach with LightCycler and it is suggested that this approach could be applicable in detection of small amounts of tumor cells in the blood of HCC patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179482     DOI: 10.3892/ijo.18.3.527

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.

Authors:  Shogo Kobayashi; Akira Tomokuni; Hidenori Takahashi; Hirofumi Akita; Keijiro Sugimura; Norikatsu Miyoshi; Jeong Ho Moon; Masayoshi Yasui; Takeshi Omori; Masayuki Ohue; Yoshiyuki Fujiwara; Masahiko Yano; Masato Sakon
Journal:  Gastrointest Tumors       Date:  2017-02-08

2.  Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.

Authors:  Osakuni Morimoto; Hiroaki Nagano; Atsushi Miyamoto; Yoshiyuki Fujiwara; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Hepatectomy based on the tumor hemodynamics for hepatocellular carcinoma: a comparison among the hybrid and pure laparoscopic procedures and open surgery.

Authors:  Shogo Kobayashi; Hiroaki Nagano; Shigeru Marubashi; Koichi Kawamoto; Hiroshi Wada; Hidetoshi Eguchi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Surg Endosc       Date:  2012-08-31       Impact factor: 4.584

4.  Effects of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Implication of circulating cancer cells by detection of α-fetoprotein mRNA.

Authors:  Masahiro Murakami; Hiroaki Nagano; Shogo Kobayashi; Hiroshi Wada; Masato Nakamura; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

Review 5.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.